These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7589188)

  • 21. Development of a model for the delta-opioid receptor pharmacophore: 3. Comparison of the cyclic tetrapeptide, Tyr-c[D-Cys-Phe-D-Pen]OH with other conformationally constrained delta-receptor selective ligands.
    Lomize AL; Pogozheva ID; Mosberg HI
    Biopolymers; 1996 Feb; 38(2):221-34. PubMed ID: 8589255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid receptor binding characteristics and structure-activity studies of novel tetrapeptides in the TIPP (Tyr-Tic-Phe-Phe) series.
    Ioja E; Tóth G; Benyhe S; Tourwe D; Péter A; Tömböly C; Borsodi A
    Neurosignals; 2005; 14(6):317-28. PubMed ID: 16772734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single diastereomeric desaminotyrosylalanyl tetra- and heptapeptides with opioid antagonistic activity.
    Balboni G; Salvadori S; D'Angeli F; Marchetti P; Lazarus LH; Bryant SD; Bianchi C
    Int J Pept Protein Res; 1995 Feb; 45(2):187-93. PubMed ID: 7782167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agonist vs antagonist behavior of delta opioid peptides containing novel phenylalanine analogues in place of Tyr(1).
    Berezowska I; Chung NN; Lemieux C; Wilkes BC; Schiller PW
    J Med Chem; 2009 Nov; 52(21):6941-5. PubMed ID: 19827750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid diketopiperazines: refinement of the delta opioid antagonist pharmacophore.
    Bryant SD; Balboni G; Guerrini R; Salvadori S; Tomatis R; Lazarus LH
    Biol Chem; 1997 Feb; 378(2):107-14. PubMed ID: 9088539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended TIP(P) analogues as precursors for labeled delta-opioid receptor ligands.
    Kumar V; Murray TF; Aldrich JV
    J Med Chem; 2000 Dec; 43(26):5050-4. PubMed ID: 11150177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects.
    Szekeres PG; Traynor JR
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1276-84. PubMed ID: 9400003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells.
    Zadina JE; Harrison LM; Ge LJ; Kastin AJ; Chang SL
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel deltorphin heptapeptide analogs with potent delta agonist, delta antagonist, or mixed mu antagonist/delta agonist properties.
    Sasaki Y; Chiba T
    J Med Chem; 1995 Sep; 38(20):3995-9. PubMed ID: 7562933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.
    Schiller PW; Nguyen TM; Weltrowska G; Wilkes BC; Marsden BJ; Lemieux C; Chung NN
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11871-5. PubMed ID: 1334552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and binding characteristics of tritiated TIPP[psi], a highly specific and stable delta opioid antagonist.
    Nevin ST; Tóth G; Weltrowska G; Schiller PW; Borsodi A
    Life Sci; 1995; 56(10):PL225-30. PubMed ID: 7885186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (2S,3R) beta-methyl-2',6'-dimethyltyrosine-L-tetrahydroisoquinoline-3-carboxylic acid [(2S,3R)TMT-L-Tic-OH] is a potent, selective delta-opioid receptor antagonist in mouse brain.
    Hosohata K; Varga EV; Alfaro-Lopez J; Tang X; Vanderah TW; Porreca F; Hruby VJ; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 2003 Feb; 304(2):683-8. PubMed ID: 12538822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and binding characteristics of the highly specific, tritiated delta opioid antagonist [3H]TIPP.
    Nevin ST; Toth G; Nguyen TM; Schiller PW; Borsodi A
    Life Sci; 1993; 53(5):PL57-62. PubMed ID: 8393120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The receptor-bound conformation of H-Tyr-Tic-(Phe-Phe)-OH-related delta-opioid antagonists contains all trans peptide bonds.
    Wilkes BC; Nguyen TM; Weltrowska G; Carpenter KA; Lemieux C; Chung NN; Schiller PW
    J Pept Res; 1998 May; 51(5):386-94. PubMed ID: 9606018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Theoretical conformational analysis of the opioid delta antagonist H-Tyr-Tic-Phe-OH and the mu agonist H-Tyr-D-Tic-Phe-NH2.
    Wilkes BC; Schiller PW
    Biopolymers; 1994 Sep; 34(9):1213-9. PubMed ID: 7948733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists.
    Tóth G; Ioja E; Tömböly C; Ballet S; Tourwé D; Péter A; Martinek T; Chung NN; Schiller PW; Benyhe S; Borsodi A
    J Med Chem; 2007 Jan; 50(2):328-33. PubMed ID: 17228874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A solid-phase synthetic strategy for labeled peptides: synthesis of a biotinylated derivative of the delta opioid receptor antagonist TIPP (Tyr-Tic-Phe-Phe-OH).
    Kumar V; Aldrich JV
    Org Lett; 2003 Mar; 5(5):613-6. PubMed ID: 12605472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
    J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid antagonist properties of the highly delta-receptor-selective BOC-Tyr-Pro-Gly-Phe-Leu-Thr (OtBu) peptide and of its Phe1 and Mel1 analogues.
    Rónai AZ; Magyar A; Orosz G; Borsodi A; Benyhe S; Tóth G; Makó E; Kátay E; Babka E; Medzihradszky K
    Arch Int Pharmacodyn Ther; 1995; 330(3):361-9. PubMed ID: 8836454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
    Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.